Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Ocugen stock in Canada | $0.316

Own Ocugen shares in just a few minutes.

Posted

Fact checked

Ocugen, Inc is a biotechnology business based in the US. Ocugen shares (OCGN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.316 – the same closing value as a week prior. Ocugen employs 16 staff and has a trailing 12-month revenue of around $42,620.

How to buy shares in Ocugen

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: OCGN in this case.
  5. Research Ocugen shares. The platform should provide the latest information available.
  6. Buy your Ocugen shares. It's that simple.

How has Coronavirus impacted Ocugen's share price?

Since the stock market crash in March caused by coronavirus, Ocugen's share price has had significant negative movement.

Its last market close was $0.316, which is 38.88% down on its pre-crash value of $0.517 and 21.54% up on the lowest point reached during the March crash when the shares fell as low as $0.26.

If you had bought $1,000 worth of Ocugen shares at the start of February 2020, those shares would have been worth $553.46 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $607.69.

Ocugen share price

Use our graph to track the performance of OCGN stocks over time.

Ocugen shares at a glance

Information last updated 2020-12-02.
Latest market close $0.316
52-week range $0.185 - $0.9577
50-day moving average $0.3031
200-day moving average $0.3337
Wall St. target price $0.9
PE ratio 0.0762
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.8349

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Buy and sell thousands of US and Canadian stocks and ETFs commission-free with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, Mutual Funds, ETFs, Currencies, Futures, Precious Metals
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are equal to or greater than US$10.00)
Min. $1.00, Max. 0.5% of trade value
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, IPOs, Precious Metals
$4.95 - $9.95
$9.95 + $1 per contract
$0
Free
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
loading

Compare up to 4 providers

Name Product Minimum deposit to invest Funding methods Management fee Available asset types
CI Direct Investing (formerly WealthBar)
$1,000
Direct deposit, Bank transfer
0.35% - 0.60%
Mutual Funds, ETFs
CI Direct Investing offers access to an exclusive and personalized investment portfolio. Get up to $10,000 managed free for a year when you sign up for your first CI Direct Investing account and fund your account.
Moka
$0
Automatic bank withdrawals
$3/month
ETFs
The Moka app rounds up every purchase you make to the nearest dollar and invests the spare change into low-cost exchange-traded funds (ETFs).
Justwealth
$5,000
Direct deposit, Bank transfer, Automatic bank withdrawals
0.50%
ETFs
Receive a cash bonus of $50.00-$225.00 when you open a new Justwealth account. RESP accounts require no minimum deposit to begin investing.
Wealthsimple Invest
$1
Direct deposit, Bank transfer
0.40% - 0.50%
Stocks, Bonds, ETFs, Commodities
Get a $50 bonus when you open and fund your first Wealthsimple Invest account with a minimum initial deposit of at least $500. Trade and Cash accounts are not eligible.
loading

Compare up to 4 providers

Name Product Minimum Opening Deposit Commission Available Markets Platforms
Forex.com
US$100
Minimum US$25
Forex
Metals
Commodities
Indices
Shares
Forex.com Desktop, Forex.com Web Trading, Forex.com Mobile Trading, MetaTrader 4
CFDs are leveraged products which involves greater risk than using cash resources only. You could lose all or more of your initial investment. Trade 80+ currency pairs and 220+ CFDs in equities, commodities and indices on Forex.com.
loading

Compare up to 4 providers

Is it a good time to buy Ocugen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Ocugen price performance over time

Historical closes compared with the last close of $0.316

1 month (2020-11-02) 14.83%
3 months (2020-09-02) 2.27%
6 months (2020-06-02) 42.99%
1 year (2019-11-29) -16.69%
2 years (2018-11-30) -26.17%
3 years (2017-11-30) -84.12%
5 years (2015-11-30) -90.40%

Is Ocugen under- or over-valued?

Valuing Ocugen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ocugen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ocugen's P/E ratio

Ocugen's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Ocugen shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Ocugen financials

Revenue TTM USD$42,620
Gross profit TTM USD$0
Return on assets TTM -38.66%
Return on equity TTM -850.6%
Profit margin 0%
Book value N/A
Market capitalisation USD$48.3 million

TTM: trailing 12 months

How to short and sell Ocugen shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "OCGN.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 5.1 million Ocugen shares held short by investors – that's known as Ocugen's "short interest". This figure is 5.8% down from 5.5 million last month.

There are a few different ways that this level of interest in shorting Ocugen shares can be evaluated.

Ocugen's "short interest ratio" (SIR)

Ocugen's "short interest ratio" (SIR) is the quantity of Ocugen shares currently shorted divided by the average quantity of Ocugen shares traded daily (recently around 3.8 million). Ocugen's SIR currently stands at 1.34. In other words for every 100,000 Ocugen shares traded daily on the market, roughly 1340 shares are currently held short.

However Ocugen's short interest can also be evaluated against the total number of Ocugen shares, or, against the total number of tradable Ocugen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ocugen's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Ocugen shares in existence, roughly 30 shares are currently held short) or 0.0328% of the tradable shares (for every 100,000 tradable Ocugen shares, roughly 33 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ocugen.

Find out more about how you can short Ocugen stock.

Ocugen share dividends

We're not expecting Ocugen to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have Ocugen's shares ever split?

Ocugen's shares were split on a 1:60 basis on 30 September 2019. So if you had owned 60 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ocugen shares – just the quantity. However, indirectly, the new 5900% higher share price could have impacted the market appetite for Ocugen shares which in turn could have impacted Ocugen's share price.

Ocugen overview

Ocugen, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of transformative therapies to cure blindness diseases. The company's pipeline product includes OCU200, a novel fusion protein that is in preclinical development stage for the treatment of wet AMD, diabetic retinopathy, and diabetic macular edema; OCU400 to treat retinitis pigmentosa, a group of rare genetic disorders; and OCU410, which is in preclinical development stage for the treatment of dry AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing. The company is headquartered in Malvern, Pennsylvania.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site